Apollomics announced that Matthew Plunkett, Ph.D., has been appointed as Chief Financial Officer, CFO, of Apollomics. Dr. Plunkett brings to Apollomics over 25 years of diverse strategic and financial experience within the biopharmaceutical sector, most recently as Chief Financial Officer at Aeovian Pharmaceuticals.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on APLM:
- Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
- Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Apollomics receives Nasdaq notification regarding minimum bid price
- Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference